Pharmaceutical Updates

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9 October 2026 in Kolkata. The...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health...

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for the...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health and Family Welfare, has issued a...

​OneSource Partners with Germany’s Formycon AG to Produce Biosimilars for Global Markets

OneSource Speciality Pharma has entered into a strategic manufacturing partnership with Germany’s Formycon AG to produce biosimilar medicines for global markets, reinforcing India's growing role as...

Trump Announces Import Taxes on Generic Drugs to Boost US Manufacturing

US President Donald Trump has announced a new phased tariff policy targeting imported generic medicines, designed tostimulate biopharmaceutical companies to establish domestic manufacturing operations within the United...

QDENGA: A Milestone in India’s Battle Against Dengue

The onset of monsoon in India apart from bringing relief from the sweltering heat marks the rise of dengue cases. Every year, lakhs of people infected by...